DFS vs MAZE
DFS (DFS) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
DFS (DFS) common stock.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
DFS does not have a complete income-statement cache yet.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
MAZE currently screens at market cap $525.3M.
Not investment advice. Open the DFS and MAZE stock pages for the full models.
Not investment advice.